Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Enzalutamide treatment of patients with advanced prostate cancer across the disease spectrum: plain language review.
Journal: Future oncology (London, England)
Published: June 30, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.
Journal: Prostate cancer and prostatic diseases
Published: February 19, 2025
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients With Low-Risk Prostate Cancer in the Community Practice.
Journal: Urology practice
Published: October 25, 2024
Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
Journal: The Journal of urology
Published: August 09, 2024
Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care.
Journal: Urology practice
Published: May 05, 2023
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
Journal: European urology oncology
Published: March 16, 2023
Defining Quality Metrics for Active Surveillance: The Michigan Urological Surgery Improvement Collaborative Experience. Letter.
Journal: The Journal of urology
Published: April 05, 2021
Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical Practice.
Journal: Reviews in urology
Published: January 01, 2020
Change in prostate cancer presentation coinciding with USPSTF screening recommendations at a community-based urology practice.
Journal: Urologic oncology
Published: February 07, 2017
Last Updated: 09/26/2026